# Amar Shah

> Amar Shah is a pre-seed investor at Dhyan VC backing Artificial Intelligence and Software. See 10 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Dhyan VC](https://shizune.co/investors/profile/dhyan-vc)
- Location: San Diego, United States
- Total investments: 10
- Last investment: May 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/amar-shah-2688691b/
- Website: https://dhyan.vc/

Amar Shah is a pre-seed investor at Dhyan VC in San Diego focused on Artificial Intelligence and Software. Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $4.8M–$15M |
| Pre-Seed | $642k–$2.3M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 4 | 40% |
| Software | 3 | 30% |
| Health Care | 3 | 30% |
| Machine Learning | 3 | 30% |
| Biotechnology | 2 | 20% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 6 | 60% |
| Seed | 3 | 30% |
| Angel | 1 | 10% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 5 | 50% |
| Poland | 1 | 10% |
| Germany | 1 | 10% |
| United States | 1 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tolemy Bio | Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies. The company focuses on precision-engineered, custom cell culture media for cell and gene therapies and biologics. Its platforms use artificial intelligence and machine learning to map how nutrients and signals influence cells. TolemyBio supports cell therapy innovators with data-driven media design and process control. Its solutions aim to improve critical quality attributes and manufacturability for advanced therapeutic products. | $1.6M | Pre-Seed | May 12, 2026 |  |
| Emm | Emm is developing the next generation of consumer health tools to manage your health on your terms. We want to empower everyone to change the quality of their life by inherently understanding their health though technology and specialist knowledge. | $8.9M | Seed | Nov 19, 2025 |  |
| ReSpo.Vision | ReSpo.Vision uses artificial intelligence to revolutionize football. It uses AI research to watch and analyze football games, providing unrivaled depth of knowledge to players, scouts, managers, clubs, and federations. | $4.8M | Seed | Jun 10, 2025 |  |
| Hippos Exoskeleton | Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries. | $642K | Pre-Seed | Nov 19, 2024 |  |
| Fractile | Fractile is building chips to run large language models two orders of magnitude faster. Existing hardware is good for training LLMs, but very poorly suited to subsequent inference of the trained model, which is increasingly the dominant workload. A network’s weights need to be moved onto a chip once per word generated, and this movement takes a fewhundred times longer than the subsequent computations themselves. Fractile’s revolutionary approach to fusing computation with memory eliminates this bottleneck, and can scale to allow running the world’s largest models at a global scale. | $14.8M | Seed | Jun 18, 2024 |  |
| Martian Lawyers Club | Martian Lawyers Club takes game personalization to the next level with the help pf generative AI. | $2.2M | Pre-Seed | Aug 31, 2023 |  |
| Coherence Neuro | Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology. | $2.3M | Pre-Seed | Mar 13, 2023 |  |
| PHINXT Robotics | PHINXT Robotics enables warehouses of any size to deploy autonomous robots as needed, with no expertise required. | $748.4K | Pre-Seed | Jan 31, 2023 |  |
| sensmore | Sensmore develops embodied physical AI and VLAM systems for use in heavy machinery. Its technologies are applied in sectors such as mining, construction, and related industries. The company focuses on enabling autonomous operations by integrating AI with machinery to support decision-making and navigation in complex environments. It designs itssystems to function under conditions where traditional automation methods may be limited. These solutions contribute to operational efficiency and reduce reliance on manual control. |  | Angel | Oct 11, 2022 |  |
| TextCortex | TextCortex is a leading European Gen AI platform that empowers businesses to transform their operations by building, managing, and interacting with customized AI Agents. We enable companies to overcome critical challenges like information silos and productivity bottlenecks, turning scattered data into actionable intelligence and deliveringsignificant ROI.Customer-Centric Value & Impact:- Massive Productivity Gains: Our customers experience a transformative boost in output, equivalent to adding on average the productivity of 13 new hires for every 100 users onboarded. - Solve the "If We Only Knew" Problem: TextCortex turns your siloed, inaccessible data into a strategic asset. Our AI Agents synthesize information **5x faster** than manual methods, deeply mining thousands of documents to provide trustworthy, context-rich answers and make information immediately interactable. Manual searches that take 5 minutes become AI-powered insights in about a minute. - Unparalleled Customization & Flexibility: With our intuitive LEGO-style editor, businesses can tailor AI Agents' data inputs, behaviors, and workflow integrations in under 5 minutes – no coding required. This ensures AI works precisely how _you_ need it to. - Future-Proof & No Vendor Lock-In: Seamlessly switch between multiple leading AI model providers (including GPTs, Claude, DeepSeek, and more), ensuring you always have access to state-of-the-art technology without being tied to a single vendor. - European Values & Enterprise-Grade Security: We prioritize data security with fully EU-hosted, GDPR & ISO compliant solutions, ensuring your data remains protected and sovereign.TextCortex is more than a platform; it's a partnership. We are obsessed with customer success, offering comprehensive user education (like our "AI Driver License" program), a phased rollout approach to maximize value, and dedicated Solution Engineering support. We see activation rates of team 100+ of 70% within the first three months.We don't just offer you software; we build long-term relationships focused on your sustained growth and efficiency.Used by global companies in Fortune 500, DAX and Global Hidden Champions serving industries such as professional services, industrial production, insurance and research.Recognized as a category leader by Gartner, Capterra, and G2 (including #20 Fastest Growing Product of 2024, #10 Best AI Software 2025, #14 Best German Software companies), TextCortex helps you build a more intelligent, productive, and secure enterprise. | $1.2M | Pre-Seed | Jun 21, 2022 |  |

10 of 10 investments shown.

## Co-investors
- [Entrepreneurs First](https://shizune.co/investors/profile/entrepreneur-first) — VC Fund, 2 deals together
- [Entrepreneurs First](https://shizune.co/investors/profile/entrepreneurs-first) — VC Fund, 2 deals together
- [NATO Innovation Fund](https://shizune.co/investors/profile/nato-innovation-fund) — VC Fund, 2 deals together
- [Possible Ventures](https://shizune.co/investors/profile/possible-ventures) — VC Fund, 2 deals together
- [Alma Angels](https://shizune.co/investors/profile/alma-angels) — VC Fund, 1 deal together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together

## About Dhyan VC

VC Fund

Dhyan VC is a venture capital firm

1 contacts available at Dhyan VC.

| Name | Title | Profile |
| --- | --- | --- |
| Amar Shah | Founder & Partner | https://shizune.co/investors/profile/amar-shah-d813 |

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar country
- [SpeedUp Venture Capital Group](https://shizune.co/investors/profile/speedup-venture-capital-group) — VC Fund
- [SMOK Ventures](https://shizune.co/investors/profile/smok-ventures) — VC Fund
- [LT Capital](https://shizune.co/investors/profile/lt-capital-5861) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors](https://shizune.co/investors/medical-device-angel-investors)
- [Biotechnology Angel Investors in United Kingdom](https://shizune.co/investors/biotechnology-angel-investors-united-kingdom)
- [Biotech Angel Investors in United Kingdom](https://shizune.co/investors/biotech-angel-investors-united-kingdom)
- [Medical Angel Investors in United Kingdom](https://shizune.co/investors/medical-angel-investors-united-kingdom)
- [Medical Device Angel Investors in United Kingdom](https://shizune.co/investors/medical-device-angel-investors-united-kingdom)
- [Life Science Angel Investors in United Kingdom](https://shizune.co/investors/life-science-angel-investors-united-kingdom)

## FAQ

### What does Amar Shah invest in?

Amar Shah invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Pre-Seed and Seed stage. Most of the 10 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Amar Shah's check size?

Amar Shah typically joins rounds of $4.8M–$15M at Seed and $642k–$2.3M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Amar Shah participates in.

### When did Amar Shah last invest?

The most recent investment recorded for Amar Shah closed in May 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co